Jacobi Capital Management LLC Grows Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Jacobi Capital Management LLC lifted its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 0.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 3,769 shares of the healthcare conglomerate’s stock after buying an additional 22 shares during the period. Jacobi Capital Management LLC’s holdings in UnitedHealth Group were worth $1,907,000 as of its most recent SEC filing.

Other hedge funds also recently bought and sold shares of the company. Jmac Enterprises LLC grew its holdings in shares of UnitedHealth Group by 2.2% during the 3rd quarter. Jmac Enterprises LLC now owns 823 shares of the healthcare conglomerate’s stock worth $481,000 after acquiring an additional 18 shares during the period. Wallace Capital Management Inc. grew its holdings in shares of UnitedHealth Group by 0.9% during the 3rd quarter. Wallace Capital Management Inc. now owns 2,119 shares of the healthcare conglomerate’s stock worth $1,239,000 after acquiring an additional 19 shares during the period. Western Pacific Wealth Management LP grew its holdings in shares of UnitedHealth Group by 2.2% during the 4th quarter. Western Pacific Wealth Management LP now owns 902 shares of the healthcare conglomerate’s stock worth $456,000 after acquiring an additional 19 shares during the period. JNBA Financial Advisors grew its holdings in shares of UnitedHealth Group by 0.4% during the 3rd quarter. JNBA Financial Advisors now owns 4,686 shares of the healthcare conglomerate’s stock worth $2,740,000 after acquiring an additional 20 shares during the period. Finally, Paragon Capital Management LLC grew its holdings in shares of UnitedHealth Group by 2.9% during the 3rd quarter. Paragon Capital Management LLC now owns 721 shares of the healthcare conglomerate’s stock worth $422,000 after acquiring an additional 20 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Insider Transactions at UnitedHealth Group

In related news, Director Timothy Patrick Flynn acquired 1,000 shares of UnitedHealth Group stock in a transaction dated Friday, January 17th. The stock was purchased at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the purchase, the director now directly owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their position. The purchase was disclosed in a filing with the SEC, which is accessible through this link. 0.33% of the stock is currently owned by company insiders.

UnitedHealth Group Price Performance

Shares of UNH opened at $474.95 on Friday. The firm has a market cap of $437.09 billion, a PE ratio of 30.64, a P/E/G ratio of 1.37 and a beta of 0.61. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The firm has a fifty day simple moving average of $516.59 and a two-hundred day simple moving average of $557.04. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. The business had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company’s quarterly revenue was up 6.8% compared to the same quarter last year. During the same period in the previous year, the business earned $5.83 EPS. On average, equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th will be paid a $2.10 dividend. The ex-dividend date of this dividend is Monday, March 10th. This represents a $8.40 annualized dividend and a dividend yield of 1.77%. UnitedHealth Group’s dividend payout ratio (DPR) is 54.19%.

Analyst Ratings Changes

A number of brokerages have recently commented on UNH. Cantor Fitzgerald reissued an “overweight” rating and issued a $700.00 price target on shares of UnitedHealth Group in a research report on Friday, January 17th. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. Piper Sandler dropped their price target on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research report on Thursday, January 2nd. KeyCorp reissued an “overweight” rating and issued a $650.00 price target on shares of UnitedHealth Group in a research report on Friday, January 17th. Finally, HSBC raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target on the stock in a research report on Friday, January 10th. One analyst has rated the stock with a hold rating, twenty have given a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Buy” and a consensus price target of $629.32.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.